Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Bosentan 32 mg Dispersible Tablets versus Tracleer® 32 mg Tablets for Oral Suspension (Tracleer® 32 mg Dispersible Tablet) (Bosentan), in healthy subjects under fasting condition.
Epistemonikos ID: a0dae42d8949ecec0c9345ca9b690f5321390f68
First added on: Apr 17, 2025